All terms in CHEBI
| Label | Id | Description |
|---|---|---|
| flurithromycin | CHEBI_131719 | [An erythromycin derivative that is erythromycin A in which the hydrogen attached to the carbon at position 8 (alpha to the ketone carbonyl group) has been replaced by a fluorine. It has been used (generally as the corresponding monoethyl succinate ester) as an antibacterial drug.] |
| erythromycin derivative | CHEBI_48924 | |
| erythromycin A | CHEBI_42355 | [An erythromycin that consists of erythronolide A having 2,6-dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl and 3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl residues attahced at positions 4 and 6 respectively.] |
| (S)-2-halocarboxylic acid | CHEBI_15791 | [Any carboxylic acid carrying an unspecified halogen substituent at the 2S-position.] |
| (S)-2-halocarboxylic acid anion | CHEBI_137405 | [A carboxylic acid anion obtained by deprotonation of the carboxy group of any (S)-2-halocarboxylic acid; major species at pH 7.3.] |
| (R)-2-halocarboxylic acid | CHEBI_15568 | [Any carboxylic acid carrying an unspecified halogen substituent at the 2R-position.] |
| rosoxacin | CHEBI_131715 | [A quinolinemonocarboxylic acid that is 1,4-dihydroquinoline-3-carboxylic acid that is substituted by an ethyl group at position 1 and by a pyridin-4-yl group at position 7. An antibacterial drug, active against Neisseria gonorrhoeae, it has been used for treating urinary tract infections and certain sexually transmitted diseases.] |
| garenoxacin | CHEBI_131716 | [A quinolinemonocarboxylic acid that is 1,4-dihydroquinoline-3-carboxylic acid that is substituted by a cyclopropyl group at position 1, an oxo group at position 4, a (1R)-1-methyl-2,3-dihydro-1H-isoindol-5-yl group at position 7, and a difluoromethoxy group at position 8.] |
| 2-epi-valiolone | CHEBI_131717 | [A cyclitol that is valiolone in which the the stereochemistry at position 2 has been inverted (from R to S).] |
| alicyclic ketone | CHEBI_36132 | [A cyclic ketone in which the carbocyclic ring structure which may be saturated or unsaturated, but may not be a benzenoid or other aromatic system.] |
| S-(1-hydroxy-2-methylbut-3-en-2-yl)glutathione(1-) | CHEBI_131718 | [An S-substitued glutathione(1-) obtained by deprotonation of the the two carboxy groups and protonation of the amino group of S-(1-hydroxy-2-methylbut-3-en-2-yl)-glutathione; major species at pH 7.3.] |
| S-substitued glutathione(1-) | CHEBI_90779 | [A peptide anion obtained by deprotonation of the carboxy groups and concomitant protonation of the amino group of any S-substitued glutathione. Major structure at pH 7.3] |
| S-(1-hydroxy-2-methylbut-3-en-2-yl)glutathione | CHEBI_132066 | [A glutathione derivative in which the thiol hydrogen of glutathione is replaced by a 1-hydroxy-2-methylbut-3-en-2-yl group.] |
| (S)-demethyl-4-deoxygadusol(1-) | CHEBI_131711 | [An organic anion obtained by deprotonation of one of the hydroxy groups of (S)-demethyl-4-deoxygadusol. It is the major microspecies at pH 7.3 (according to Marvin v 6.2.0.).] |
| (S)-demethyl-4-deoxygadusol | CHEBI_132052 | [A member of the class of cyclohexenones that is 5-(hydroxymethyl)cyclohex-2-en-1-one carrying three additional hydroxy substituents at positions 2, 3 and 5.] |
| 1-(4-amino-2-methylpyrimidin-5-ylmethyl)-3-(2-hydroxyethyl)-2-methylpyridinium bromide | CHEBI_15797 | [A pyridinium salt that is 1-(4-amino-2-methylpyrimidin-5-ylmethyl)-3-(2-hydroxyethyl)-2-methylpyridinium having bromide as the counterion.] |
| pyrithiamine | CHEBI_72290 | [A pyridinium ion that is 3-(2-hydroxyethyl)-2-methylpyridine substituted at position 1 by a (4-amino-2-methylpyrimidin-5-yl)methyl group.] |
| shinorine | CHEBI_131712 | [A mycosporine-like amino acid that is the ketimine resulting from the formal condensation of the amino group of L-2-aminobutanoic acid with the keto group of (5S)-5-hydroxy-5-(hydroxymethyl)-2-methoxycyclohex-2-en-1-one in which the hydrogen at position 3 of the cyclohexenone moiety has been replaced by the amino group of glycine.] |
| mycosporine-like amino acid | CHEBI_35738 | [Water-soluble UV-absorbing secondary metabolites characterized by a cyclohexenone or cycloheximine chromophore conjugated with the nitrogen substituents of amino acids or their imino alcohols. They typically have absorption maxima ranging from 309 to 360 nm and an average molecular weight of around 300. They occur in taxonomically diverse organisms.] |
| ultraviolet filter | CHEBI_73335 | [A photochemical role realized in the absorption of ultraviolet light, for example to protect skin cells from damage.] |